Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Phospholipase A2 Receptor Gene Polymorphisms Alter its Functions and Present a Genetic Risk of an Increased Intima-Media Thickness of the Carotid Artery.

Si NV, Fujioka D, Watanabe K, Watanabe Y, Watanabe K, Nakamura K, Yamaguchi K, Uematsu M, Kugiyama K.

J Atheroscler Thromb. 2016 Oct 1;23(10):1227-1241.

2.

Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Ramanadham S, Ali T, Ashley JW, Bone RN, Hancock WD, Lei X.

J Lipid Res. 2015 Sep;56(9):1643-68. doi: 10.1194/jlr.R058701. Review.

3.

A new era of secreted phospholipase A₂.

Murakami M, Sato H, Miki Y, Yamamoto K, Taketomi Y.

J Lipid Res. 2015 Jul;56(7):1248-61. doi: 10.1194/jlr.R058123.

4.

Inhibition of nicotinic acetylcholine receptors, a novel facet in the pleiotropic activities of snake venom phospholipases A2.

Vulfius CA, Kasheverov IE, Starkov VG, Osipov AV, Andreeva TV, Filkin SY, Gorbacheva EV, Astashev ME, Tsetlin VI, Utkin YN.

PLoS One. 2014 Dec 18;9(12):e115428. doi: 10.1371/journal.pone.0115428.

5.

Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.

Fujita M, Zhu K, Fujita CK, Zhao M, Lam KS, Kurth MJ, Takada YK, Takada Y.

J Biol Chem. 2015 Jan 2;290(1):259-71. doi: 10.1074/jbc.M114.579946.

6.

Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.

Quach ND, Mock JN, Scholpa NE, Eggert MW, Payré C, Lambeau G, Arnold RD, Cummings BS.

Mol Pharm. 2014 Oct 6;11(10):3443-51. doi: 10.1021/mp500174p.

8.

Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth.

Vindrieux D, Devailly G, Augert A, Le Calvé B, Ferrand M, Pigny P, Payen L, Lambeau G, Perrais M, Aubert S, Simonnet H, Dante R, Bernard D.

Oncotarget. 2014 Feb 28;5(4):1004-13.

9.

Complex determinants in specific members of the mannose receptor family govern collagen endocytosis.

Jürgensen HJ, Johansson K, Madsen DH, Porse A, Melander MC, Sørensen KR, Nielsen C, Bugge TH, Behrendt N, Engelholm LH.

J Biol Chem. 2014 Mar 14;289(11):7935-47. doi: 10.1074/jbc.M113.512780.

10.

Neurotoxicity in snakebite--the limits of our knowledge.

Ranawaka UK, Lalloo DG, de Silva HJ.

PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2302. doi: 10.1371/journal.pntd.0002302. Review.

11.

Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.

Coenen MJ, Hofstra JM, Debiec H, Stanescu HC, Medlar AJ, Stengel B, Boland-Augé A, Groothuismink JM, Bockenhauer D, Powis SH, Mathieson PW, Brenchley PE, Kleta R, Wetzels JF, Ronco P.

J Am Soc Nephrol. 2013 Mar;24(4):677-83. doi: 10.1681/ASN.2012070730.

12.

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ.

N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.

13.

Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Titsworth WL, Liu NK, Xu XM.

CNS Neurol Disord Drug Targets. 2008 Jun;7(3):254-69. Review.

14.

Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.

Saegusa J, Akakura N, Wu CY, Hoogland C, Ma Z, Lam KS, Liu FT, Takada YK, Takada Y.

J Biol Chem. 2008 Sep 19;283(38):26107-15. doi: 10.1074/jbc.M804835200.

15.

Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity.

Rouault M, Rash LD, Escoubas P, Boilard E, Bollinger J, Lomonte B, Maurin T, Guillaume C, Canaan S, Deregnaucourt C, Schrével J, Doglio A, Gutiérrez JM, Lazdunski M, Gelb MH, Lambeau G.

Biochemistry. 2006 May 9;45(18):5800-16.

16.

Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis.

Balestrieri B, Hsu VW, Gilbert H, Leslie CC, Han WK, Bonventre JV, Arm JP.

J Biol Chem. 2006 Mar 10;281(10):6691-8.

17.
18.

Signal transduction in esophageal and LES circular muscle contraction.

Harnett KM, Cao W, Kim N, Sohn UD, Rich H, Behar J, Biancani P.

Yale J Biol Med. 1999 Mar-Jun;72(2-3):153-68. Review.

19.

Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand.

Liu Y, Chirino AJ, Misulovin Z, Leteux C, Feizi T, Nussenzweig MC, Bjorkman PJ.

J Exp Med. 2000 Apr 3;191(7):1105-16.

20.

A cysteine-rich domain of the "mannose" receptor mediates GalNAc-4-SO4 binding.

Fiete DJ, Beranek MC, Baenziger JU.

Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2089-93.

Items per page

Supplemental Content

Support Center